Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Journal of Neuro-Oncology
|
October 7, 2020
Response to trametinib treatment in progressive pediatric low-grade glioma patients
Florian Selt, Cornelis M van Tilburg, Brigitte Bison, et al.
Journal of Inherited Metabolic Disease
|
November 18, 2016
Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision
Nikolas Boy, Chris Mühlhausen, Esther M Maier, et al.
Neurogenetics
|
January 16, 2020
POLR3A variants with striatal involvement and extrapyramidal movement disorder
Inga Harting, Murtadha Al-Saady, Ingeborg Krägeloh-Mann, et al.
Journal of Inherited Metabolic Disease
|
July 2, 2024
MRI in LARS1 deficiency-Spectrum, patterns, and correlation with acute neurological deterioration
Nicole Hammann, Dominic Lenz, Alyssa Bianzano, et al.
BMC Cancer
|
June 7, 2020
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies
Cornelis M van Tilburg, Ruth Witt, Melanie Heiss, et al.
European Journal of Human Genetics : EJHG
|
January 12, 2022
Complementing the phenotypical spectrum of TUBA1A tubulinopathy and its role in early-onset epilepsies
Julian Schröter, Bernt Popp, Heiko Brennenstuhl, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
February 9, 2018
SCYL1 variants cause a syndrome with low γ-glutamyl-transferase cholestasis, acute liver failure, and neurodegeneration (CALFAN)
Dominic Lenz, Patricia McClean, Aydan Kansu, et al.
Neurology
|
May 12, 2019
Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study
Martha Nowosielski, Thierry Gorlia, Jacoline E C Bromberg, et al.
Neurological Research and Practice
|
October 18, 2023
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas
Niklas Grassl, Katharina Sahm, Heike Süße, et al.
The New England Journal of Medicine
|
November 16, 2017
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick, Thierry Gorlia, Martin Bendszus, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Journal of Neuro-Oncology
|
October 7, 2020
Response to trametinib treatment in progressive pediatric low-grade glioma patients
Florian Selt, Cornelis M van Tilburg, Brigitte Bison, et al.
Journal of Inherited Metabolic Disease
|
November 18, 2016
Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision
Nikolas Boy, Chris Mühlhausen, Esther M Maier, et al.
Neurogenetics
|
January 16, 2020
POLR3A variants with striatal involvement and extrapyramidal movement disorder
Inga Harting, Murtadha Al-Saady, Ingeborg Krägeloh-Mann, et al.
Journal of Inherited Metabolic Disease
|
July 2, 2024
MRI in LARS1 deficiency-Spectrum, patterns, and correlation with acute neurological deterioration
Nicole Hammann, Dominic Lenz, Alyssa Bianzano, et al.
BMC Cancer
|
June 7, 2020
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies
Cornelis M van Tilburg, Ruth Witt, Melanie Heiss, et al.
European Journal of Human Genetics : EJHG
|
January 12, 2022
Complementing the phenotypical spectrum of TUBA1A tubulinopathy and its role in early-onset epilepsies
Julian Schröter, Bernt Popp, Heiko Brennenstuhl, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
February 9, 2018
SCYL1 variants cause a syndrome with low γ-glutamyl-transferase cholestasis, acute liver failure, and neurodegeneration (CALFAN)
Dominic Lenz, Patricia McClean, Aydan Kansu, et al.
Neurology
|
May 12, 2019
Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study
Martha Nowosielski, Thierry Gorlia, Jacoline E C Bromberg, et al.
Neurological Research and Practice
|
October 18, 2023
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas
Niklas Grassl, Katharina Sahm, Heike Süße, et al.
The New England Journal of Medicine
|
November 16, 2017
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick, Thierry Gorlia, Martin Bendszus, et al.
Page
of 6